The Day the Pope Met a Psychedelic Evangelist
Pharmacological Perennialism crossed paths with the Catholic Church at a previously unreported "holy meeting."
Pharmacological Perennialism crossed paths with the Catholic Church at a previously unreported "holy meeting."
Making DOI and DOC Schedule I drugs would interfere with psychiatric research.
Trippy author Ernesto Londoño points out that supposedly ancient psychedelic rituals don't always lead to great outcomes.
Despite a few bright spots, the disappointing returns suggest that the road to pharmacological freedom will be rockier than activists hoped.
The initiative also would have authorized state-licensed "psychedelic therapy centers."
The ballot initiatives would allow recreational marijuana use in Florida and the Dakotas, authorize medical marijuana in Nebraska, and decriminalize five natural psychedelics in Massachusetts.
This Kentucky Republican won't stop until he finds a state willing to make legal room for ibogaine, a drug he calls "God's medicine."
This Kentucky Republican won't stop until he finds a state willing to make legal room for ibogaine, a drug he calls "God's medicine."
An FDA advisory committee concluded that MDMA's benefits had not been shown to outweigh its risks.
The FDA, which approved the protocols for the studies it now questions, is asking for an additional Phase 3 clinical trial, which would take years and millions of dollars.
The agency claims DOI and DOC have "a high potential for abuse" because they resemble other drugs it has placed in Schedule I.
The now-dead bill would have permitted three counties to establish pilot programs in which military veterans could take psilocybin under the supervision of medical professionals.
The panel's recommendation, based on several concerns about two clinical trials, is a serious setback for a promising PTSD treatment.
The head of Students for Sensible Drug Policy clarifies the misconceptions around decriminalization, safe injection sites, and whether Trump or Biden is better on drug policy.
I asked artificial intelligence to tell me how to take psychedelic mushrooms.
The former Cheers producer talks faith, ayahuasca, and what it’ll take to bring back the blockbuster comedy.
Mind-altering drugs have long been seen as tools for both liberation and control.
The sequel is about ecology, politics, economics, imperialism, and much more. But mostly it's about worms.
In 2024, the FDA will decide whether or not MDMA can be used to treat patients suffering from PTSD.
Intoxicants might be a source of problems—or enhance our ability to cope.
Comedian Shane Mauss on the democratization of mushrooms, LSD, cannabis, DMT, and ketamine
The death of the Friends star should remind us of the costs of the war on drugs.
The psychedelic comedian talks cognitive liberty and the mind-blowing pace of legalization efforts.
Newsom vetoed both reforms, which he deemed excessively permissive.
Historian Erika Dyck contextualizes the deep roots of and battles over LSD, psilocybin, and other psychoactive substances.
The former Texas governor spoke with Reason's Nick Gillespie at the Psychedelic Science 2023 conference in Denver.
The former Texas governor on helping veterans with PTSD, increasing legal immigration, and the illegal drug he'd most like to try
Historian Erika Dyck wants to document the deep roots of and battles over LSD, psilocybin, and other psychoactive substances.
Plus: The Biden administration weighs a "remain in Texas" policy, California slowly but surely reforms its housing-killing environmental review law, and more...
The founder of MAPS talks about FDA approval for MDMA-assisted therapy and the "psychedelic renaissance" he has helped create.
The Colorado governor finds common ground with many libertarians. But does he really stand for more freedom?
Reason's Nick Gillespie talked with Mauss, a comedian who tours the country discussing his psychedelic experiences, at the Psychedelic Science 2023 conference.
The former Texas governor on helping veterans with PTSD, increasing legal immigration, and the illegal drug he'd most like to try
Reason's Nick Gillespie talked with MAPS founder Rick Doblin about the imminent FDA approval of MDMA- and psilocybin-assisted therapy at the Psychedelic Science conference in Denver.
"I can tell you none of us were affected by the mushrooms," Yellen insisted to CNN.
Inside the gathering of the scientists, psychonauts, capitalists, and comedians committed to mainstreaming psychedelics without repeating the errors of the 1960s.
The libertarian comedian on why he's dreading the presidential election season, how he survived COVID, and why he needs to do more psychedelics.
The comedian has entertained audiences with his bad taste and unapologetically libertarian tirades for nearly 30 years.
"Government in general does a lot of things that aren't necessary," says Jared Polis.
Some doctors are itching to prescribe ecstasy again. How do we avoid the regulatory mistakes of the '80s?
Join Reason on YouTube and Facebook Thursday at 1 p.m. Eastern for a discussion about the path to full drug legalization in America.
A documentary short about a woman who takes ayahuasca to alleviate the pain caused by addiction
As the drug war retreats, individualist approaches to substance use and abuse will make us all better off.
Andrew Tatarsky and Maia Szalavitz push individualist approaches to substance abuse as the drug war retreats.
A ballot initiative approved in November decriminalizes consumption of natural psychedelics.
S.B. 58, which emulates an initiative that Colorado voters approved last month, would legalize the use of five psychoactive substances found in fungi and plants.
Do you care about free minds and free markets? Sign up to get the biggest stories from Reason in your inbox every afternoon.
This modal will close in 10